Tata Elxsi and Viridium AI launch ViTel for medical device manufacturers

Tata Elxsi has announced the launch of ViTel, a Material Intelligence solution for medical device manufacturers, co-developed with Viridium AI. ViTel is being introduced at DeviceTalks Boston 2026, where Tata Elxsi is presenting developments in AI-powered MedTech engineering and compliance.

Medical device manufacturers are facing increasing pressure as material decisions impact margin, resilience, product timelines, and market access. Critical product information remains distributed across bills of materials (BOMs), supplier documents, ERP and PLM systems, and internal teams, making regulatory and customer compliance processes dependent on manual effort.

ViTel has been developed to create a reusable Material Intelligence layer across enterprises. The platform helps teams identify material and supplier dependencies, assess sourcing and country-of-origin exposure, evaluate alternatives, and understand how material or product risks impact cost, continuity, and market access.

Powered by Viridium AI’s Knowledge Cloud, Chemical Digital Twin, and science-constrained AI models, ViTel converts enterprise data into a connected product-material knowledge graph linking products, parts, materials, chemicals, suppliers, regulations, and supporting evidence.

The platform also incorporates Tata Elxsi’s experience in MedTech engineering and regulatory services, integrating this knowledge into material risk assessment, compliance analysis, and sourcing workflows.

Tata Elxsi contributes design-led and AI-first engineering capabilities, healthcare and MedTech domain expertise, and enterprise access, while Viridium AI provides the technology platform and innovation framework.

Sreevatsa Sahasranaman said, “ViTel brings Material Intelligence directly into the product and compliance workflows that matter most, helping our customers make faster, more confident decisions across sourcing, engineering, quality, and regulatory readiness.”

Niraj Deo said, “Viridium AI was built to help manufacturers understand the material DNA of their products. In Med-Tech, that intelligence creates a strategic foundation for the manufacturer. Once product and material knowledge are digitized, it becomes a reusable enterprise asset for margin, sourcing, engineering, quality, and regulatory decisions. Partnering with Tata Elxsi through ViTel brings that capability directly into the hands of the teams who need it most.”

Muthusamy Selvaraj said, “The question that led to ViTel was a simple one: what could the world’s best material intelligence capability become if it truly understood healthcare? That question is how this partnership with Viridium AI was born, and how STEP UP works in practice. We are accountable for the outcome. That is what makes this model different.”

ViTel has been co-developed through STEP UP, Tata Elxsi’s co-innovation programme for deep-tech companies.